90 likes | 104 Views
We provide KLSE trading recommendations in which stocks to buy, hot shares to watch, penny stocks trade, market updates TOP Gainers, TOP Losers, best stock trading recommendations. For 3 Days free trial visits our website.
E N D
4-APR-2019 Market Commentary Market Statistics Economic Calendar Index Analysis Daily Stock Signals Please refer to disclaimer at the end of report www.epicresearch.my
4-APR-2019 Malaysia Stock Market Continuous buying by funds and gains on heavyweights helped propel the benchmark FBM KLCI index higher on Wednesday. At closing, the bellwether FBM KLCI added 10.38 points, or 0.64%, to close at 1,643.21 on strong interest in Genting Group stocks as well banking stocks. The market traded within a range of 9.74 points between an intra-day high of 1,645.54 and a low of 1,635.80 during the session. In the broader market, there were 490 gainers, 329 losers while 414 counters unchanged. Trading volume stood at 2.66 billion shares worth RM1.93bil. Dealers said continued buying in selected heavyweights pushed the key index to finish higher buoyed by the progress over US-China trade talks. In today’s session, 22 of the KLCI-component stocks were traded higher, seven counters fell while the remaining one closed unchanged. Major stock advancers among the FBM KLCI component stocks included IHH Healthcare, which gained 18 sen to RM5.60, Public Bank added 30 sen to RM23, Genting rose 25 sen to RM6.85 and Genting Malaysia advanced 11 sen to RM3.28. Laggards in the FBM KLCI component stocks included Maxis, which fell four sen to RM5.49, Tenaga declined four sen to RM12.54 and Petronas Chemicals shed two sen to RM9.08. TOP 5 Stocks by Trading Value Counter Name Last Change Volume MYEG 1.42 -0.04 138,660 KNM 0.15 +0.025 132,413 SAPNRG 0.355 0.00 94,945 PWORTH 0.065 +0.005 83,847 VS 1.07 0.00 62,949 www.epicresearch.my KLSE Market Insight By Epic Research MALAYSIA Please refer to disclaimer at the end of report www.epicresearch.my
4-APR-2019 TOP 5 Gainers Counter Name Last Change Volume PANAMY 37.80 +0.52 1 NESTLE 146.50 +0.40 11 PBBANK 23.00 +0.30 6,661 GENTING 6.95 +0.25 3,851 HSI-C5F 1.26 +0.25 12 TOP 5 Losers Counter Name Last Change Volume CARLSBG 26.30 -0.50 79 RAPID 5.57 -0.15 2,203 TIMECOM 8.56 -0.14 1,502 BKAWAN 16.90 -0.10 1 KESM 8.40 -0.10 43 Dividends Counter Name Date Subject Change % WILLOW 4-APR-19 Dividend RM 0.01 RHBBANK 4-APR-19 Dividend RM 0.13 GENTING 4-APR-19 Dividend RM 0.06 GENP 4-APR-19 Dividend RM 0.0825 GENM 4-APR-19 Dividend RM 0.05 Please refer to disclaimer at the end of report www.epicresearch.my
4-APR-2019 TOP 5 % Gainer Counter Name Code Last Change MYEG-C48 13848 0.02 0.015 MENANG-WB [S] 1694WB 0.01 0.005 CBIP-WA [S] 7076WA 0.01 0.005 MERIDIAN-WB [S] 5040WB 0.025 0.01 KNM-WB [S] 7164WB 0.025 0.01 TOP 5 % Loser Counter Name Code Last Change MAYBANKC53 115553 0.06 -0.09 SUMATEC[S] 1201 0.005 -0.005 E&O-C14 341714 0.085 -0.065 COMCORP 7195 0.055 -0.03 AHB-WB[S] 7315WB 0.01 -0.005 TOP 5 % Shariah Compliant Gainer Counter Name Code Last Change MENANG-WB[S] 1694WB 0.01 0.005 CBIP-WA[S] 7076WA 0.01 0.005 MERIDIAN-WB[S] 5040WB 0.025 0.01 KNM-WB[S] 7164WB 0.025 0.01 MAHSING-WC[S] 8583WC 0.015 0.005 Please refer to disclaimer at the end of report www.epicresearch.my
4-APR-2019 Sector- Indices Last Done Change Volume CONSTRUCTION 196.56 2.16 1,013,176 CONSUMER PRODUCTS & SERVICES 684.33 5.88 2,124,539 ENERGY 1,058.72 10.9 4,747,340 FINANCIAL SERVICES 16,898.86 77.22 404,138 HEALTH CARE 1,240.98 10.8 294,678 INDUSTRIAL PRODUCTS & SERVICES 169.13 0.52 3,084,450 PLANTATION 7,218.10 36.06 750,728 PROPERTY 911.7 5.77 1,229,388 REIT 992.31 -0.81 100,331 TECHNOLOGY 32.93 -0.03 2,355,103 TELECOMMUNICATIONS & MEDIA 683.8 5.36 210,160 TRANSPORTATION & LOGISTICS 772.72 2.68 315,510 UTILITIES 994.77 4.01 131,827 FBMACE 4,834.34 -2.77 2,226,315 FBMAPMYR 17,357.59 99.93 735,610 Please refer to disclaimer at the end of report www.epicresearch.my
4-APR-2019 MAJOR ECONOMIC EVENTS Time Cur. Imp. Event Actual Forecast Previous Monday, April 1, 2019 03:55 EUR German Manufacturing PMI (Mar) 44.1 44.7 44.7 04:30 GBP Manufacturing PMI (Mar) 55.1 51.2 52.1 05:00 EUR CPI (YoY) (Mar) 1.4% 1.5% 1.5% 08:30 USD Core Retail Sales (MoM) (Feb) -0.4% 0.4% 1.4% 08:30 USD Retail Sales (MoM) (Feb) -0.2% 0.3% 0.7% 10:00 USD ISM Manufacturing PMI (Mar) 55.3 54.5 54.2 14:55 CAD BoC Gov Poloz Speaks 23:30 AUD RBA Interest Rate Decision (Apr) 1.50% 1.50% 1.50% 23:30 AUD RBA Rate Statement Tuesday, April 2, 2019 04:30 GBP Construction PMI (Mar) 49.7 49.8 49.5 Core Durable Goods Orders (MoM) (Feb) 49 min USD 0.3% -0.2% 20:30 AUD Retail Sales (MoM) (Feb) 0.3% 0.1% Wednesday, April 3, 2019 04:30 GBP Services PMI (Mar) 50.9 51.3 ADP Nonfarm Employment Change (Mar) 08:15 USD 184K 183K 10:00 USD ISM Non-Manufacturing PMI (Mar) 58.0 59.7 10:30 USD Crude Oil Inventories -1.175M 2.800M Thursday, April 4, 2019 02:15 INR Interest Rate Decision 6.00% 6.25% 03:30 GBP Construction PMI (Mar) 49.8 49.5 ECB Publishes Account of Monetary Policy Meeting 07:30 EUR 10:00 CAD Ivey PMI (Mar) 51.1 50.6 Friday, April 5, 2019 All Day Holiday Hong Kong - Ching Ming Festival All Day Holiday China - Ching Ming Festival 08:30 USD Nonfarm Payrolls (Mar) 175K 20K 08:30 USD Unemployment Rate (Mar) 3.8% 3.8% 08:30 CAD Employment Change (Mar) 1.0K 55.9K Please refer to disclaimer at the end of report www.epicresearch.my
4-APR-2019 GENTING[S] BUY GENTING 6.960 TARGET 8.004 SL 6.264 INTRADAY OUTLOOK:- SUPPORT– 6.960 RESISTANCE– 8.004 MARKET STRATEGY– LONG RELATIVE STRENGTH INDEX(RSI) - 53.491 Please refer to disclaimer at the end of report www.epicresearch.my
4-APR-2019 FKLI The benchmark FTSE Bursa Malaysia KLCI (FBM KLCI) gained +10.380 points ended 1643.210 to after hovering 1645.540 throughout the day. The RSI at 37.907 Please refer to disclaimer at the end of report www.epicresearch.my
4-APR-2019 DISCLAIMER The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor- made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations . The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken. Please refer to disclaimer at the end of report www.epicresearch.my